testicular germ cell tumor

睾丸生殖细胞肿瘤
  • 文章类型: Journal Article
    背景:生发睾丸肿瘤是20~34岁男性中最常见的恶性肿瘤。即使它们不寻常,在过去的十年中,它们的发病率增加;它们在五年时具有良好的预后和总体生存率,约95%。关于患者的治疗选择存在不同的数据,第二,和第三复发与常规治疗。一些研究描述了使用大剂量化疗与骨髓移植相关的可能益处,结果可变。
    方法:本研究描述了临床结果,临床反应,死亡率,总生存率,一组生发恶性肿瘤患者的无进展生存期为两年,精原细胞瘤与非精原细胞瘤,首先有疾病进展的证据,第二,或第三种常规化疗方案,并在2010年至2021年期间在美国国家癌症研究所接受了高剂量化疗和骨髓移植。
    结果:一项病例系列的回顾性观察性研究表明,57%的三线治疗患者接受了大剂量化疗和骨髓移植,从诊断开始的中位疾病进展时间超过两年。移植后患者出现感染性并发症(71%)。最常见的是发热性中性粒细胞减少症(29%),死亡率为71%(n=5)。无进展生存期2.3个月,总生存期为7.4个月。
    结论:这些结果表明,在这组患者中,与骨髓移植相关的大剂量化疗方案,与其他患者相比,预后较差,并且可能不是这种抢救疗法的最佳候选人。
    BACKGROUND: Germinal testicular tumors are the most common malignant neoplasm in men around 20 to 34 years. Even though they are unusual, they have increased incidence in the last decade; they have an excellent prognosis and overall survival at five years, approximately 95%. Divergent data exists regarding treatment options in patients with first, second, and third relapses with conventional therapy. Some studies describe the possible benefit of using high-dose chemotherapy associated with a bone marrow transplant with variable results.
    METHODS:  The present study describes clinical outcomes, clinical response, mortality, overall survival, and progression-free survival to two years in a group of patients with germinal malignant tumors, seminoma versus non-seminomatous with evidence of progression of the disease at first, second, or third conventional chemotherapy regimens, and who received high dose chemotherapy and bone marrow transplantation at the National Cancer Institute between 2010 and 2021.
    RESULTS: A retrospective observational study of case series showed that 57% of patients in third-line therapy received high-dose chemotherapy and bone marrow transplantation, with progression disease median time from diagnosis more than two years. Patients in the post-graft period presented infectious complications (71%). The most common were febrile neutropenia (29%) with a mortality rate of 71% (n=5), progression-free survival of 2.3 months, and overall survival of 7.4 months.
    CONCLUSIONS:  These results show that in this group of patients, regimens with high-dose chemotherapy associated with bone marrow transplants, have a worse prognosis compared to other cohorts of patients, and may not be the best candidates for this rescue therapy.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    这项研究旨在探讨青少年和年轻人(AYAs)在睾丸生殖细胞肿瘤(TGCT)治疗后可能经历后期影响的性行为的观点和担忧。进行了一项定性研究,其中对来自荷兰TGCT专业中心的13个AYA进行了半结构化访谈。数据采用Braun和Clark的专题分析方法进行分析。发现了七个相互作用和相互联系的主题:想要孩子,重新发现性,关于性表现的不安全感,接受物理变化,失去男子气概,关系的负担,以及讨论性的开放性。对想要孩子的担忧似乎发挥了重要作用。总之,TGCT患者面临多种变化(身体,情感,关系,和性),接下来是一段艰难的接受期,之后,重新发现性的新阶段出现了。这些发现有助于使医疗保健专业人员意识到有关性行为的潜在机制和担忧。此外,见解可以帮助开发以性为主题的项目,作为更广泛的监测工具,从结构上评估后期影响,以支持讨论性。
    This study aimed to explore perspectives and concerns regarding sexuality among adolescents and young adults (AYAs) possibly experiencing late effects after testicular germ cell tumor (TGCT) treatment. A qualitative study was performed in which semi-structured interviews were held with thirteen AYAs from a center of expertise for TGCT in the Netherlands. Data were analyzed using Braun and Clark\'s thematic analysis method. Seven interacting and interconnected themes were found: desire to have children, rediscovering sexuality, insecurity about sexual performance, acceptance of physical change, loss of masculinity, burden on relationship, and openness in discussing sexuality. Concerns about the desire to have children seem to play a significant role. In conclusion, TGCT patients face multiple changes (physical, emotional, relational, and sexual), followed by a difficult period of acceptance, after which a new phase of rediscovering sexuality appeared. These findings can help to make healthcare professionals aware of the underlying mechanisms and concerns about sexuality. Furthermore, insights can help to develop sexuality-themed items for a broader monitoring tool to structurally assess the late effects to support discussing sexuality.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    睾丸生殖细胞肿瘤(TGCT)在年轻男性中相对常见,做出准确的诊断和预后评估至关重要。microRNAs(miRNAs),包括microRNA-371a-3p(miR-371a-3p),已显示出有望作为TGCT的生物标志物。这篇综述讨论了miRNA生物标志物在TGCT中的最新进展,重点关注围绕畸胎瘤非侵入性检测的挑战。循环miR-371a-3p,它在未分化的TGCT中表达,但在畸胎瘤中不表达,是TGCT的有前途的生物标志物。其在血清中的检测,等离子体,and,潜在的,囊性液体可用于TGCT诊断,监视,和监测治疗反应。其他miRNA,如miR-375-3p和miR-375-5p,已被调查以区分TGCT亚型(畸胎瘤,坏死/纤维化,和可行的肿瘤),可以帮助做出治疗决定。然而,畸胎瘤的可靠标记物尚未确定。miRNA生物标志物的临床应用可以使患者免于不必要的手术,并允许更个性化的治疗方法。特别是在化疗后残留肿块大于1厘米的患者中,区分可行的肿瘤至关重要,畸胎瘤,和坏死/纤维化。畸胎瘤,模仿体细胞组织,在差异化方面提出了挑战,需要全面的诊断方法。miR-371和miR-375的组合显示出提高诊断精度的潜力。有助于区分畸胎瘤,有活力的肿瘤,和坏死。在TGCT护理中实施miRNA生物标志物可以改善患者的预后,减少过度治疗,并促进个性化的治疗策略。然而,目前仍缺乏可靠的畸胎瘤标志物.未来的研究应该集中在这些生物标志物的临床验证和标准化上,以充分发挥其潜力。
    Testicular germ cell tumors (TGCTs) are relatively common in young men, making accurate diagnosis and prognosis assessment essential. MicroRNAs (miRNAs), including microRNA-371a-3p (miR-371a-3p), have shown promise as biomarkers for TGCTs. This review discusses the recent advancements in the use of miRNA biomarkers in TGCTs, with a focus on the challenges surrounding the noninvasive detection of teratomas. Circulating miR-371a-3p, which is expressed in undifferentiated TGCTs but not in teratomas, is a promising biomarker for TGCTs. Its detection in serum, plasma, and, potentially, cystic fluid could be useful for TGCT diagnosis, surveillance, and monitoring of therapeutic response. Other miRNAs, such as miR-375-3p and miR-375-5p, have been investigated to differentiate between TGCT subtypes (teratoma, necrosis/fibrosis, and viable tumors), which can aid in treatment decisions. However, a reliable marker for teratoma has yet to be identified. The clinical applications of miRNA biomarkers could spare patients from unnecessary surgeries and allow for more personalized therapeutic approaches. Particularly in patients with residual masses larger than 1 cm following chemotherapy, it is critical to differentiate between viable tumors, teratomas, and necrosis/fibrosis. Teratomas, which mimic somatic tissues, present a challenge in differentiation and require a comprehensive diagnostic approach. The combination of miR-371 and miR-375 shows potential in enhancing diagnostic precision, aiding in distinguishing between teratomas, viable tumors, and necrosis. The implementation of miRNA biomarkers in TGCT care could improve patient outcomes, reduce overtreatment, and facilitate personalized therapeutic strategies. However, a reliable marker for teratoma is still lacking. Future research should focus on the clinical validation and standardization of these biomarkers to fully realize their potential.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    睾丸生殖细胞肿瘤(TGCT)是发达国家年轻男性中最常见的癌症。父母在生命早期的职业暴露被怀疑会增加TGCT风险。目的是评估出生时父母职业与成人TGCT之间的关联。
    进行了病例对照研究,包括来自20个法国大学医院的454例18-45岁的TGCT病例,根据地区和出生年份与670个对照相匹配。从参与者那里收集的数据包括根据1968年国际标准职业分类和1999年法国活动术语编码的出生时的父母工作。TGCT的赔率(OR)和95%置信区间(CI)使用条件逻辑回归进行估计,调整TGCT危险因素。
    出生时作为服务工作者的父亲工作(OR=1.98,CI1.18-3.30),防护服务人员(OR=2.40,CI1.20-4.81),运输设备运营商(OR=1.96,CI1.14-3.37),专业农民(OR=2.66,CI1.03-6.90),作为中等教育教师(OR=2.27,CI1.09-4.76)或中等教育(OR=2.35,CI1.13-4.88)的产妇工作与成人TGCT显着相关。上述父系工作的精原细胞瘤风险增加,公共管理和国防的非精原细胞瘤风险增加;强制性社会保障(OR=1.99,CI1.09-3.65);一般,经济,父亲的社会管理(OR=3.21,CI1.23-8.39);母亲的中学教育老师(OR=4.67,CI1.87-11.67)和中学教育(OR=3.50,CI1.36-9.01)。
    一些父亲的工作,比如服务人员,运输设备运营商,或者专业农民,中等教育中的产妇工作似乎与TGCT的风险增加有关,TGCT具有特定的特征,具体取决于组织学类型。这些数据允许提出假设,以便进一步研究职业暴露参与发展TGCT的风险,比如接触杀虫剂,溶剂,或者重金属。
    Testicular germ cell tumors (TGCT) are the most frequent cancer in young men in developed countries. Parental occupational exposures during early-life periods are suspected to increase TGCT risk. The objective was to estimate the association between parental occupations at birth and adult TGCT.
    A case-control study was conducted, including 454 TGCT cases aged 18-45 from 20 French university hospitals, matched to 670 controls based on region and year of birth. Data collected from participants included parental jobs at birth coded according to the International Standard Classification of Occupation-1968 and the French nomenclature of activities-1999. Odds ratios (OR) for TGCT and 95% confidence intervals (CI) were estimated using conditional logistic regression, adjusting for TGCT risk factors.
    Paternal jobs at birth as service workers (OR = 1.98, CI 1.18-3.30), protective service workers (OR = 2.40, CI 1.20-4.81), transport equipment operators (OR = 1.96, CI 1.14-3.37), specialized farmers (OR = 2.66, CI 1.03-6.90), and maternal jobs as secondary education teachers (OR = 2.27, CI 1.09-4.76) or in secondary education (OR = 2.35, CI 1.13-4.88) were significantly associated with adult TGCT. The risk of seminoma was increased for the above-mentioned paternal jobs and that of non-seminomas for public administration and defence; compulsory social security (OR = 1.99, CI 1.09-3.65); general, economic, and social administration (OR = 3.21, CI 1.23-8.39) for fathers; and secondary education teacher (OR = 4.67, CI 1.87-11.67) and secondary education (OR = 3.50, CI 1.36-9.01) for mothers.
    Some paternal jobs, such as service workers, transport equipment operators, or specialized farmers, and maternal jobs in secondary education seem to be associated with an increased risk of TGCT with specific features depending on the histological type. These data allow hypotheses to be put forward for further studies as to the involvement of occupational exposures in the risk of developing TGCT, such as exposure to pesticides, solvents, or heavy metals.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Case Reports
    在原发性或转移性睾丸生殖细胞肿瘤(TGCT)中,体细胞型恶性肿瘤(STM)很少发生,并且与预后和生存不良有关。具有软骨肉瘤特征的STM极为罕见,并且以前没有记录过头颈部受累。一名39岁的白人男子出现鼻塞和鼻出血。影像学显示有6.9厘米的扩张性肿瘤,累及鼻腔和颅底,并伴有眶内和颅内延伸。肿瘤的组织病理学特性与软骨肉瘤一致,II-III级。免疫组织化学,恶性细胞对S100和上皮标志物呈强烈和弥漫性阳性,并显示SMARCB1表达缺失。未检测到IDH1/2突变。全身PET扫描后,发现了一个7.0厘米的左睾丸肿块,并诊断为带有合胞体滋养层细胞的精原细胞瘤,阶段pT3NXM1b。广泛的腹膜后,纵隔,并注意到锁骨上淋巴结肿大。左锁骨上淋巴结的组织病理学检查显示转移性精原细胞瘤。由FISH,大多数转移性淋巴结精原细胞瘤细胞含有1至4个拷贝的12p同工染色体,而软骨肉瘤表现为12p的重复。存在恶性TGCT伴播散性膈上淋巴结病,颅骨软骨肉瘤的独特免疫表型特性和缺乏IDH1/2像差,增益为12p,强烈支持了转移性TGCT引起的STM软骨肉瘤的诊断.患者对化疗无反应,诊断后三个月死亡。虽然非常罕见,TGCT患者可能发生头颈部转移。与头颈部软骨肉瘤的“典型”实例相比,该STM软骨肉瘤病例表现出不同的免疫表型和分子特征。对于具有其他典型组织形态学但意外的免疫组织化学或分子特征的病变,建议高度怀疑。
    Somatic-type malignancy (STM) can occur infrequently within a primary or metastatic testicular germ cell tumor (TGCT) and is associated with dismal prognosis and survival. STM with chondrosarcomatous features is exceedingly rare and head and neck involvement has not been previously documented. A 39-year-old white man presented with nasal obstruction and epistaxis. Imaging disclosed a 6.9-cm expansile tumor involving the nasal cavity and skull base with intraorbital and intracranial extension. The histopathologic properties of the tumor were compatible with chondrosarcoma, grade II-III. Immunohistochemically, malignant cells were strongly and diffusely positive for S100 and epithelial markers, and showed loss of SMARCB1 expression. IDH1/2 mutations were not detected. Following whole-body PET scan, a 7.0-cm left testicular mass was discovered and diagnosed as seminoma with syncytiotrophoblastic cells, stage pT3NXM1b. Extensive retroperitoneal, mediastinal, and supraclavicular lymphadenopathy was also noticed. Histopathologic examination of the left supraclavicular lymph node revealed metastatic seminoma. By FISH, most metastatic nodal seminoma cells harbored 1 to 4 copies of isochromosome 12p, while the chondrosarcoma featured duplication of 12p. Presence of a malignant TGCT with disseminated supradiaphragmatic lymphadenopathy, the unique immunophenotypic properties of the skull-based chondrosarcoma and lack of IDH1/2 aberrations with gain of 12p strongly support the diagnosis of STM chondrosarcoma arising from metastatic TGCT. The patient did not respond to chemotherapy and succumbed three months after diagnosis. Although exceedingly uncommon, metastasis to the head and neck may occur in patients with TGCT. This case of STM chondrosarcoma demonstrated divergent immunophenotypic and molecular characteristics compared to \"typical\" examples of head and neck chondrosarcoma. High index of suspicion is advised regarding the diagnosis of lesions that present with otherwise typical histomorphology but unexpected immunohistochemical or molecular features.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Case Reports
    睾丸癌,占男性恶性肿瘤的1-1.5%,很少双边呈现,只有2-3%的病例是双边的,只有10%是同步的,通常在两个睾丸中共享组织学模式。不一致的组织学表现非常罕见,只有少数病例报告。在这份报告中,我们详细介绍了一例35岁男性不育,双侧睾丸肿瘤,每个都表现出不同的组织病理学。这种情况凸显了诊断的复杂性以及面对这种罕见的表现时进行量身定制管理的必要性。肿瘤治疗和保留生育能力的意义显著影响患者的整体生活质量。
    Testicular cancer, accounting for 1-1.5% of male malignancies, rarely presents bilaterally, with only 2-3% of cases being bilateral and a mere 10% being synchronous, typically sharing histological patterns in both testes. Discordant histological presentation is exceedingly rare, with only a few reported cases. In this report, we detail a case involving a 35-year-old infertile male with bilateral synchronous testicular tumors, each exhibiting different histopathologies. This case highlights the diagnostic intricacies and the necessity for tailored management in the face of such uncommon presentations. The implications of oncological treatment and fertility preservation significantly affect the patient\'s overall quality of life.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    睾丸生殖细胞肿瘤(TGCT)经常影响青少年和年轻成年男性。尽管TGCT对基于顺铂的化疗比其他实体瘤更敏感,有些病人是无应答者,在治疗之后,许多患者继续经历以顺铂为基础的化疗的急性和长期细胞毒性作用.因此,必须开发新的治疗耐药TGCT的治疗模式.肽基氨酰异构酶(Pin1)调节许多癌症相关靶蛋白的活性和稳定性。先前的发现表明Pin1有助于多种人类癌症的发病机理。然而,Pin1在TGCT中的具体功能尚未阐明。用KPT6566处理后,使用细胞周期分析和凋亡测定法检查TGCT细胞增殖和活力,与Pin1的催化结构域共价结合的选择性Pin1抑制剂。使用异种移植小鼠模型来评估KPT6566对体内肿瘤生长的影响。KPT6566有效抑制细胞增殖,菌落形成,和P19和NCCIT细胞中的ATP产生。Further,KPT6566通过产生细胞活性氧并下调胚胎转录因子Oct-4和Sox2诱导凋亡细胞死亡。最后,KPT6566处理显著减小了P19细胞异种移植物中的肿瘤体积和质量。Pin1抑制剂KPT6566在TGCT细胞中具有显著的抗增殖和抗肿瘤作用。这些发现表明Pin1抑制剂可以被认为是TGCT的潜在治疗方法。
    Testicular germ cell tumors (TGCTs) frequently affect adolescent and young adult males. Although TGCT is more responsive to cisplatin-based chemotherapy than other solid tumors, some patients are nonresponders, and following treatment, many patients continue to experience acute and long-term cytotoxic effects from cisplatin-based chemotherapy. Consequently, it is imperative to develop new therapeutic modalities for treatment-resistant TGCTs. Peptidyl-prolyl isomerase (Pin1) regulates the activity and stability of many cancer-associated target proteins. Prior findings suggest that Pin1 contributes to the pathogenesis of multiple human cancers. However, the specific function of Pin1 in TGCTs has not yet been elucidated. TGCT cell proliferation and viability were examined using cell cycle analysis and apoptosis assays following treatment with KPT6566, a potent, selective Pin1 inhibitor that covalently binds to the catalytic domain of Pin1. A xenograft mouse model was used to assess the effect of KPT6566 on tumor growth in vivo. KPT6566 effectively suppressed cell proliferation, colony formation, and ATP production in P19 and NCCIT cells. Further, KPT6566 induced apoptotic cell death by generating cellular reactive oxygen species and downregulating the embryonic transcription factors Oct-4 and Sox2. Finally, KPT6566 treatment significantly reduced tumor volume and mass in P19 cell xenografts. The Pin1 inhibitor KPT6566 has significant antiproliferative and antitumor effects in TGCT cells. These findings suggest that Pin1 inhibitors could be considered as a potential therapeutic approach for TGCTs.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Case Reports
    睾丸生殖细胞肿瘤伴体细胞型恶性肿瘤,其中畸胎瘤转化为肉瘤,耐药,预后不良。
    一名43岁男子出现左睾丸肿瘤,多发性肺转移,纵隔和主动脉旁淋巴结转移。睾丸肿瘤诊断为生殖细胞肿瘤。博来霉素之后,依托泊苷,顺铂化疗;右上叶切除术治疗肺转移;紫杉醇,异环磷酰胺,顺铂化疗,纵隔淋巴结转移迅速进展。由于具有挑战性的手术方法,它在另一个专门的中心被切除。切除肿瘤的组织病理学诊断是畸胎瘤,伴有体细胞型恶性肿瘤(横纹肌肉瘤)。随后,肺转移均行左肺门淋巴结转移切除术和左上肺叶切除术。患者在初始治疗后存活超过8年。
    手术,虽然具有挑战性,可能获得长期生存的睾丸生殖细胞肿瘤与肉瘤转化的患者。
    UNASSIGNED: Testicular germ cell tumors with somatic-type malignancy, wherein teratomas transform into sarcomas, is drug resistant and has a poor prognosis.
    UNASSIGNED: A 43-year-old man presented with a left testicular tumor, multiple pulmonary metastases, and mediastinal and para-aortic lymph node metastases. The testicular tumors were diagnosed as germ cell tumors. After bleomycin, etoposide, and cisplatin chemotherapy; right upper lobectomy for the pulmonary metastasis; and paclitaxel, ifosfamide, and cisplatin chemotherapy, rapidly progressing mediastinal lymph node metastasis was observed. It was resected at another specialized center owing to the challenging surgical approach. The histopathological diagnosis of the resected tumor was a teratoma with somatic-type malignancy (rhabdomyosarcoma). Subsequently, left hilar lymph node metastasectomy and left upper lobectomy were performed for the pulmonary metastases. The patient survived for more than 8 years after initial treatment.
    UNASSIGNED: Surgery, although challenging, may yield long-term survival for patients with testicular germ cell tumors with sarcomatous transformation.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    目的:体力活动(PA)可能减轻睾丸生殖细胞肿瘤(TGCT)长期存活者以顺铂为基础的化疗的晚期心脏代谢毒性。在这项横断面研究中,我们评估了习惯性PA对代谢综合征(MetS)患病率的影响,以及长期TGCT幸存者的心脏代谢健康和慢性炎症标志物。
    方法:评估了MetS患病率,和习惯性PA使用Baecke的习惯性PA问卷评估TGCT幸存者(n=195,年龄=41.1±8.1岁,治疗后11.7±5.2年)和健康男性对照(n=41,年龄=38.2±8.8岁)。根据中位数将参与者分为低PA和高PA组。检查了低PA组和高PA组之间的差异(在整个样本中,TGCT幸存者子样本在疾病阶段不同,和健康的控制),以及TGCT幸存者和对照组之间。接下来,TGCT幸存者根据治疗后时间(5-15/15/30年)和化疗周期数(≤3/>3)分为年龄和BMI匹配的亚组,允许我们在给定的TGCT幸存者亚群中检测习惯性PA对心脏代谢健康的年龄和BMI无关的影响。产生了习惯性PA和运动活动与心脏代谢和促炎标志物的相关矩阵。
    结果:TGCT幸存者的MetS患病率高于对照组。高习惯性PA患者腰围较低,全身炎症指数较低。习惯性PA评分与HDL-胆固醇呈正相关,与腰围和致动脉粥样硬化风险呈负相关。此外,习惯性PA的心脏代谢获益在疾病1期和2期患者中更为显著.习惯性PA对按化疗剂量和治疗后时间分层的患者亚群的影响清楚地表明,习惯性PA水平较高与MetS成分数量较低相关。除了接受超过3个化疗周期且在治疗后超过15年接受检查的患者。
    结论:较高水平的习惯性PA可有效减轻TGCT幸存者的心脏代谢毒性。化疗累积剂量较高的患者可能需要进行包括高强度体力活动的结构化运动干预,以实现心脏代谢健康的显着改善。
    OBJECTIVE: Physical activity (PA) may mitigate late cardiometabolic toxicity of cisplatin-based chemotherapy in testicular germ cell tumor (TGCT) long-term survivors. In this cross-sectional study, we evaluated the effects of habitual PA on metabolic syndrome (MetS) prevalence, and on the markers of cardiometabolic health and chronic inflammation in a population of long-term TGCT survivors.
    METHODS: MetS prevalence was evaluated, and habitual PA was assessed using Baecke\'s habitual PA questionnaire in TGCT survivors (n=195, age=41.1±8.1years, 11.7±5.2years post-therapy) and healthy male controls (n=41, age=38.2±8.8years). Participants were stratified into low- and high-PA groups based on median values. Differences were examined between low- and high-PA groups (in the entire sample, TGCT survivor sub-samples differing in disease stage, and healthy controls), and between TGCT survivors and controls. Next, TGCT survivors were stratified into age- and BMI-matched sub-groups based on post-treatment time (5-15/15/30years) and number of chemotherapy cycles (≤3/>3), allowing us to detect age- and BMI-independent effects of habitual PA on cardiometabolic health in the given TGCT survivor sub-populations. A correlation matrix of habitual PA and sport activity with cardiometabolic and pro-inflammatory markers was generated.
    RESULTS: TGCT survivors had higher MetS prevalence than controls. Patients with high habitual PA had lower waist circumference and Systemic Inflammation Index. Habitual PA scores correlated positively with HDL-cholesterol and negatively with waist circumference and atherogenic risk. Furthermore, cardiometabolic benefits of habitual PA were more pronounced in patients with disease stages 1 and 2. Effects of habitual PA on patients sub-populations stratified by chemotherapy dose and post-treatment time clearly showed that higher levels of habitual PA were associated with lower numbers of MetS components, except for patients who received more than 3 chemotherapy cycles and were examined more than15 years post-therapy.
    CONCLUSIONS: Higher levels of habitual PA effectively mitigated cardiometabolic toxicity in TGCT survivors. Patients with higher cumulative doses of chemotherapy may need structured exercise interventions involving higher-intensity physical activity to achieve significant improvements in cardiometabolic health.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Case Reports
    睾丸生殖细胞肿瘤是年轻和中年男性的睾丸肿瘤。未下降的睾丸会大大增加睾丸生殖细胞肿瘤的风险。我们报告了一名33岁的男性,他抱怨下腹部肿胀和疼痛。患者还有一个未下降的左睾丸。在超声上检测到腹内肿块,并使用对比增强CT进一步表征。影像学检查结果提示睾丸生殖细胞肿瘤,发展为未降睾丸的并发症。患者进行了手术,并通过组织病理学检查确认了诊断。
    Testicular germ cell tumors are testicular neoplasms in young and middle-aged men. Undescended testis dramatically increases the risk of testicular germ cell tumors. We report the case of a 33-year-old male who complained of swelling and pain in his lower abdomen. The patient also had an undescended left testis. An intrabdominal mass was detected on ultrasound that was further characterized using contrast-enhanced CT. Imaging findings suggested testicular germ cell tumor, developing as a complication in the undescended testis. The patient was operated and the diagnosis was confirmed on histopathological examination.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

公众号